Skip to main content
. 2023 Apr 26;18:2225–2238. doi: 10.2147/IJN.S400467

Figure 5.

Figure 5

The in vivo anti-HIRI effect of MnOx-CeO2 NPs. (A) ALT level in the serum of different groups, (B) AST level in the serum of different groups, (C) MDA level in the liver of different groups, (D) SOD level in the liver of different groups, (E) H&E staining of liver tissue sections in different groups, ① cell necrosis with hepatic cord disintegration and hemorrhage, ② cytoplasmic vacuolar degeneration, ③ focal nuclear pyknosis. * denotes P<0.05, ** denotes P<0.01.